August 9, 2023 Landmark paper in Nature Communications highlights continued advances in Evox Therapeutics’s proprietary exosome engineering platform
August 4, 2023 Evox Therapeutics enters into agreement to advance next generation exosome-delivered AAV gene therapy for the treatment of heart disease
May 17, 2023 Evox Therapeutics Granted Key US Exosome Purification Patent to Further Expand Its Leading Patent Portfolio
May 12, 2023 Evox Therapeutics Presents Progress Across its DeliverEX® Platform Highlighting Advances in Exosome-Mediated Delivery of Genetic Medicines Including Gene Editing and RNA Therapeutics
May 26, 2022 Evox Therapeutics Presents Progress Across its DeliverEX™ Exosome Therapeutics Platform with Nine Presentations at the International Society for Extracellular Vesicles (ISEV) Annual Meeting
May 19, 2022 EVOX THERAPEUTICS ANNOUNCES DATA PRESENTATIONS AT THE INTERNATIONAL SOCIETY FOR EXTRACELLULAR VESICLES (ISEV) ANNUAL MEETING
May 9, 2022 INTERNATIONAL SOCIETY FOR CELL & GENE THERAPY PRESENTATIONS ILLUSTRATE EVOX THERAPEUTICS’ PROPRIETARY EXOSOME ENGINEERING PLATFORM WITH NEW DATA ON EXOSOME TARGETING AND IN VIVO DISTRIBUTION
October 7, 2021 LANDMARK PAPER HIGHLIGHTS EVOX THERAPEUTICS’ CUTTING EDGE EXOSOME ENGINEERING APPROACH FOR ENHANCED SURFACE DISPLAY OF BIOLOGICS
May 4, 2021 EVOX TO PRESENT NEW EXOSOME ENGINEERING ADVANCES AT THE AMERICAN SOCIETY FOR GENE AND CELL THERAPY (ASGCT) ANNUAL MEETING
November 17, 2020 EVOX THERAPEUTICS ANNOUNCES LAUNCH OF STRATEGIC COLLABORATION WITH THE UNIVERSITY OF OXFORD
